Skip to main content

IVIG Treatment in Immune-mediated Necrotizing Myopathy

Drs. Caoilfhionn Connolly interviews Dr. Asim Mohamed about abstract 1164, IVIG Treatment Duration in Immune-mediated Necrotizing Myopathy and a Possible Association of Vacuolar Changes with Black/African American Female Patients, presented at the 2024 ACR Convergence meeting in Washington, DC.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×